tiprankstipranks
Trending News
More News >
Svas Biosana S.p.A. (IT:SVS)
:SVS
Italy Market

Svas Biosana S.p.A. (SVS) Stock Forecast & Price Target

Compare
1 Followers
See the Price Targets and Ratings of:

SVS Financial Forecast

SVS Earnings Forecast

The previous quarter’s earnings for SVS were €0.62.
The previous quarter’s earnings for SVS were €0.62.

SVS Sales Forecast

The previous quarter’s earnings for SVS were €70.42M.
The previous quarter’s earnings for SVS were €70.42M.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TP ICAP MIDCAP Analyst forecast on IT:SVS
Unknown Analyst
TP ICAP MIDCAP
Not Ranked
TP ICAP MIDCAP
€12.9
Buy
60.85%
Upside
Reiterated
09/29/25
TP ICAP Reaffirms Buy Rating for Svas Biosana S.p.A. Amid Strong Financial Performance and Strategic Growth
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TP ICAP MIDCAP Analyst forecast on IT:SVS
Unknown Analyst
TP ICAP MIDCAP
Not Ranked
TP ICAP MIDCAP
€12.9
Buy
60.85%
Upside
Reiterated
09/29/25
TP ICAP Reaffirms Buy Rating for Svas Biosana S.p.A. Amid Strong Financial Performance and Strategic Growth
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Svas Biosana S.p.A.

3 Months
xxx
Success Rate
0/0 ratings generated profit
Average Return
0.00%
reiterated a xxx
rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in - of your transactions generating a profit, with an average return of 0.00% per trade.
1 Year
Unknown AnalystTP ICAP MIDCAP
Not Ranked
Success Rate
0/0 ratings generated profit
Average Return
0.00%
reiterated a buy rating 3 months ago
Copying Unknown Analyst's trades and holding each position for 1 Year would result in - of your transactions generating a profit, with an average return of 0.00% per trade.
2 Years
xxx
Success Rate
0/0 ratings generated profit
Average Return
0.00%
reiterated a xxx
rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in - of your transactions generating a profit, with an average return of 0.00% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

SVS Analyst Recommendation Trends

Rating
Feb 25
Apr 25
May 25
Jun 25
Sep 25
Strong Buy
3
3
3
3
3
Buy
0
0
0
0
0
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
3
3
3
3
3
In the current month, SVS has received 3 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. SVS average Analyst price target in the past 3 months is .
Each month's total comprises the sum of three months' worth of ratings.

SVS Stock Forecast FAQ

What is IT:SVS’s average 12-month price target, according to analysts?
Currently, no data Available
What is IT:SVS’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for IT:SVS, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is Svas Biosana S.p.A. a Buy, Sell or Hold?
      Svas Biosana S.p.A. has a consensus rating of Moderate Buy, which is based on 0 buy ratings, 0 hold ratings and 0 sell ratings.
        What is Svas Biosana S.p.A.’s share price target?
        Currently, no data Available
        What do analysts say about Svas Biosana S.p.A.?
        Svas Biosana S.p.A.’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 0 Wall Streets Analysts.
          How can I buy shares of Svas Biosana S.p.A.?
          To buy shares of IT:SVS, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.